Mercury General
MERCURY GENERAL CORPORATION
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$6.0B
Operating marginCalculated
Could not be retrieved
Net assets to total assetsCalculated
Could not be retrieved
Company profile
Tables scroll sideways
Disclosed data
Profitability
Could not be retrieved
Growth (revenue, 4-year average)
★★★★☆position among all companies
10.7%
Capital efficiency
Could not be retrieved
Revenue and profit
Performance, financial position and capital allocation
Mercury General
Recent performance trends
Mercury General
Cash flow trends
Consolidated indicators (7 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$4.0 billion | US$3.6 billion | US$4.6 billion | US$5.5 billion | US$6.0 billion |
| Net income | US$0.2 billion | US$-0.5 billion | US$96.34 million | US$0.5 billion | US$0.5 billion |
| Total assets | US$6.8 billion | US$6.5 billion | US$7.1 billion | US$8.3 billion | US$9.6 billion |
| Net cash provided by (used in) operating activities | US$0.5 billion | US$0.4 billion | US$0.5 billion | US$1.0 billion | US$1.1 billion |
| Net cash provided by (used in) investing activities | US$-0.4 billion | US$-0.3 billion | US$-0.3 billion | US$-0.8 billion | US$-0.4 billion |
| Net cash provided by (used in) financing activities | US$-0.1 billion | US$-81.99 million | US$0.1 billion | US$-71.11 million | US$-71.72 million |
| Cash and cash equivalents | US$0.3 billion | US$0.3 billion | US$0.6 billion | US$0.7 billion | US$1.3 billion |
Revenue scale in the same industry
Mercury General
Insurance carriers: 54 companies · revenue · largest first・FY Dec 2025・Consolidated・Disclosed
- 1 UnitedHealth Group US$447.6B
- 2 Berkshire Hathaway US$371.4B
- 3 The Cigna Group US$274.9B
- … 40 companies
- 44 Pruco Life Insurance US$6.0B
- 45 Globe Life US$6.0B
- 46 Mercury GeneralThis company US$6.0B
- 47 F&G Annuities & Life US$5.7B
- 48 Selective Insurance Group US$5.3B
- … 6 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$58.43 million | Consolidated | Disclosed |
| Cash and cash equivalents | US$1.3 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-71.72 million | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-0.4 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$1.1 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$74.99 million | Consolidated | Disclosed |
| Dividends paid | US$70.34 million | Consolidated | Disclosed |
| Stockholders' equity (including non-controlling interests) | US$2.4 billion | Consolidated | Disclosed |
| Net sales | US$6.0 billion | Consolidated | Disclosed |
| Net income | US$0.5 billion | Consolidated | Disclosed |
| Total assets | US$9.6 billion | Consolidated | Disclosed |
| Operating margin | Cannot be calculated | Not applicable | Not calculated (no operating income in this year's 10-K) |
| Net assets to total assets | Cannot be calculated | Not applicable | Not calculated (no stockholders' equity in this year's 10-K) |
| Net margin | 9.0% | Consolidated | Calculated |
| Return on equity | Cannot be calculated | Not applicable | Not calculated (no stockholders' equity in this year's 10-K) |